CY1109710T1 - Επιτοπα βοηθητικων τ λεμφοκυτταρων - Google Patents

Επιτοπα βοηθητικων τ λεμφοκυτταρων

Info

Publication number
CY1109710T1
CY1109710T1 CY20091101243T CY091101243T CY1109710T1 CY 1109710 T1 CY1109710 T1 CY 1109710T1 CY 20091101243 T CY20091101243 T CY 20091101243T CY 091101243 T CY091101243 T CY 091101243T CY 1109710 T1 CY1109710 T1 CY 1109710T1
Authority
CY
Cyprus
Prior art keywords
epitopes
lymphocyte
auxiliary site
taaqitaglalhqsnln
sgrrqrrfagvvlagva
Prior art date
Application number
CY20091101243T
Other languages
English (en)
Inventor
David Charles Jackson
Souravi Ghosh
John Walker
Original Assignee
The University Of Melbourne
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AUPP8533A external-priority patent/AUPP853399A0/en
Priority claimed from AUPQ2013A external-priority patent/AUPQ201399A0/en
Application filed by The University Of Melbourne filed Critical The University Of Melbourne
Publication of CY1109710T1 publication Critical patent/CY1109710T1/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18411—Morbillivirus, e.g. Measles virus, canine distemper
    • C12N2760/18422—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Detergent Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Luminescent Compositions (AREA)

Abstract

Η παρούσα εφεύρεση παρέχει επίτοπα και συνθέσεις βοηθητικών Τ λεμφοκυττάρων για χρήση στην επαγωγή μίας ανοσολογικής απόκρισης που περιλαμβάνει τουλάχιστον ένα από αυτά τα επίτοπα. Τα επίτοπα περιέχονται στην ακολουθία πεπτιδίων που επιλέγεται από την ομάδα που αποτελείται από SSKTQTHTQQDRPPQPS. QPSTELEETRTSRARHS. RHSTTSAQRSTHYDPRT. PRTSDRPVSYTMNRTRS. TRSRKQTSHRLKNIPVH. SHQYLVIKLIPNASLIE. IGTDNVHYIKIMTRPSHQ. YKIMTRPSHQYLVIKLI- KLIPNASLIENCTKAEL. AELGEYEKLLNSVLEPI. EPINQALTLMTKNVKPL. FAGVVLAGVALGVATAA. TAAQITAGLALHQSNLN. GIALHQSNLNAQAIQSL. NLNAQAIQSLRTSLEQS. QSLRTSLEQSNKAIEEI. EQSNKAIEEIREATQET. TELLSIFGPSLRDPISA. PRYIATNGYLISNFDES. CIRGDTSSCARTLVSGT. DESSCVFVSESAICSQN. TSTIINQSPDKLLTFIA, SPDKLLTFIASDTCPLV και SGRRQRRFAGVVLAGVA.
CY20091101243T 1999-02-05 2009-11-26 Επιτοπα βοηθητικων τ λεμφοκυτταρων CY1109710T1 (el)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AUPP8533A AUPP853399A0 (en) 1999-02-05 1999-02-05 T helper cell epitopes
AUPQ2013A AUPQ201399A0 (en) 1999-08-04 1999-08-04 T-helper cell epitopes
EP00906047A EP1147212B1 (en) 1999-02-05 2000-02-07 T helper cell epitopes

Publications (1)

Publication Number Publication Date
CY1109710T1 true CY1109710T1 (el) 2014-08-13

Family

ID=25645983

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20091101243T CY1109710T1 (el) 1999-02-05 2009-11-26 Επιτοπα βοηθητικων τ λεμφοκυτταρων

Country Status (15)

Country Link
US (5) US6685947B1 (el)
EP (2) EP2103691A1 (el)
JP (2) JP4699612B2 (el)
KR (2) KR100955668B1 (el)
AT (1) ATE440960T1 (el)
AU (1) AU765164B2 (el)
CA (1) CA2361658C (el)
CY (1) CY1109710T1 (el)
DE (1) DE60042816D1 (el)
DK (1) DK1147212T3 (el)
ES (1) ES2332701T3 (el)
NZ (1) NZ513482A (el)
PT (1) PT1147212E (el)
WO (1) WO2000046390A1 (el)
ZA (1) ZA200106413B (el)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ513482A (en) * 1999-02-05 2003-08-29 Univ Melbourne T helper cell epitodes derived from canine distemper virus for producing an immune response in an animal
US20050106137A1 (en) * 2000-05-05 2005-05-19 Stephen Grimes Chimeric peptide immunogens
US20030045467A1 (en) * 2001-01-05 2003-03-06 Tihamer Orban Autoantigen composition
AU2003249778B2 (en) 2002-08-12 2010-09-23 The Council Of The Queensland Institute Of Medical Research Novel immunogenic lipopeptides comprising T-helper and cytotoxic T lymphocyte (CTL) epitopes
CN1688606B (zh) 2002-08-12 2013-12-25 昆士兰医学研究所理事会 含有辅助t细胞和b细胞表位的新的免疫原性脂肽
US7178491B2 (en) * 2003-06-05 2007-02-20 Caterpillar Inc Control system and method for engine valve actuator
US8354380B2 (en) 2004-06-17 2013-01-15 Mannkind Corporation NY-ESO-1 peptide analogs
WO2006026834A1 (en) 2004-09-10 2006-03-16 The Council Of The Queensland Institute Of Medical Research (Qimr) Truncated lhrh formulations
AU2005282231B2 (en) * 2004-09-10 2011-03-10 The Council Of The Queensland Institute Of Medical Research (Qimr) Truncated LHRH formulations
CN101448517A (zh) 2005-04-19 2009-06-03 伊莱利利公司 用于疾病免疫干预的单价和多价合成多糖抗原
BRPI0611390A2 (pt) * 2005-06-01 2010-09-08 Pfizer Prod Inc composições de vacina e uso de composições compreendendo vacina anti-lhrh na preparação de um medicamento para tratar incontinência urinária
SG162817A1 (en) 2005-06-17 2010-07-29 Mannkind Corp Methods and compositions.to elicit multivalent immune responses against dominant and subdominant epitopes, expressed on cancer cells and tumor stroma
BRPI0611793A2 (pt) * 2005-06-17 2009-01-13 Mannkind Corp anÁlogos de epÍtopo
WO2007127787A2 (en) * 2006-04-25 2007-11-08 Joslin Diabetes Center, Inc. Insulin autoantigen-specific regulatory cd4+ t cells
CO2021017322A1 (es) * 2021-12-16 2023-06-20 Univ Cooperativa De Colombia Péptidos inmunogénicos contra el virus distemper canino (cdv)
CN115960262A (zh) * 2022-10-19 2023-04-14 四川农业大学 展示cdv抗原表位的犬细小病毒样颗粒及构建方法和应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5047238A (en) 1983-06-15 1991-09-10 American Home Products Corporation Adjuvants for vaccines
US6309647B1 (en) * 1999-07-15 2001-10-30 Aventis Pasteur Poxvirus—canine dispemper virus (CDV) or measles virus recombinants and compositions and methods employing the recombinants
US5756102A (en) * 1990-11-20 1998-05-26 Virogenetics Corporation Poxvirus-canine distemper virus (CDV) recombinants and compositions and methods employing the recombinants
JP2001513120A (ja) 1997-02-11 2001-08-28 ザ カウンシル オブ ザ クイーンズランド インスティチュート オブ メディカル リサーチ ペプチドを含むポリマー
NZ513482A (en) * 1999-02-05 2003-08-29 Univ Melbourne T helper cell epitodes derived from canine distemper virus for producing an immune response in an animal

Also Published As

Publication number Publication date
JP2002536384A (ja) 2002-10-29
US20070248615A1 (en) 2007-10-25
CA2361658C (en) 2013-04-09
US7097844B2 (en) 2006-08-29
EP2103691A1 (en) 2009-09-23
AU2783600A (en) 2000-08-25
WO2000046390A1 (en) 2000-08-10
KR100905264B1 (ko) 2009-06-29
DK1147212T3 (da) 2010-01-04
NZ513482A (en) 2003-08-29
KR100955668B1 (ko) 2010-05-06
KR20010101796A (ko) 2001-11-14
JP2011121965A (ja) 2011-06-23
DE60042816D1 (de) 2009-10-08
US7241448B2 (en) 2007-07-10
EP1147212B1 (en) 2009-08-26
US6685947B1 (en) 2004-02-03
JP4699612B2 (ja) 2011-06-15
PT1147212E (pt) 2009-12-03
US7572454B2 (en) 2009-08-11
US7037507B2 (en) 2006-05-02
ZA200106413B (en) 2002-08-05
US20060199177A1 (en) 2006-09-07
US20050186220A1 (en) 2005-08-25
ATE440960T1 (de) 2009-09-15
CA2361658A1 (en) 2000-08-10
ES2332701T3 (es) 2010-02-11
US20050037014A1 (en) 2005-02-17
EP1147212A4 (en) 2004-03-31
AU765164B2 (en) 2003-09-11
EP1147212A1 (en) 2001-10-24
KR20090015892A (ko) 2009-02-12

Similar Documents

Publication Publication Date Title
CY1109710T1 (el) Επιτοπα βοηθητικων τ λεμφοκυτταρων
CY1113379T1 (el) Πεπτιδια κdr και εμβολια που τα περιλαμβανουν
CY1113421T1 (el) Πυρηνικα οξεα και πολυπεπτιδια υποδοχεα
CY1108083T1 (el) Αντιγονα και συνθεσεις του neisseria meningitidis
CY1108299T1 (el) Πεπτιδια του ιου ανθρωπινης ανοσοανεπαρκειας (hiv), αντιγονα και συνθεσεις εμβολιου
CY1119291T1 (el) Πολυσθενη αντισωματα και χρησεις για αυτα
ATE196314T1 (de) Verfahren und zusammensetzungen zur verhinderung von entzündungen und angiogenese enthaltend säugetieren cd97 alpha untereinheit
CY1118443T1 (el) Anti-tnf αντισωματα, συνθεσεις, μεθοδοι και χρησεις
TR199900848T2 (xx) Oksadiazoller, elde edilmeleri ve ila� olarak kullan�mlar�.
PE20030316A1 (es) Sistema de suministro de dos o mas agentes terapeuticamente activos
ATE463505T1 (de) Toll-ähnlichen-rezeptor-5-liganden und verwendungsverfahren
FR2763244B1 (fr) Composition vaccinale multivalente a porteur mixte
CY1107628T1 (el) Ανθρωπινα ctla-4 αντισωματα και χρησεις αυτων
NO20044039L (no) Konjugatorer av terapeutiske eller cytotoksiske midler og biologisk aktive peptider.
CY1109439T1 (el) Αναλογα γλυκοπρωτεϊνικων ορμονων δισουλφιδικης σταυρωτης συνδεσης, η παρασκευη και η χρηση τους
SE9704546D0 (sv) Novel compounds
ES2193145T3 (es) Proteinas procoagulants quimericas.
CY1109699T1 (el) Νουκλεινικα οξεα που κωδικοποιουν πολυπεπτιδια πολυεπιτοπων
CY1117746T1 (el) Αντιγονα αιμοφιλου της γριπης και αντιστοιχα θραυσματα dna
CY1105008T1 (el) Αντιμικροβιακη ενεργοτητα του πρωτου κατιονικου συγκροτηματος της ανθρωπινης λακτοφερρινης
DE69938935D1 (de) Zyklische conotoxin-peptide
ATE326237T1 (de) Miscmicellen aus lipopeptiden für induzierung einer immunantwort
CY1109812T1 (el) Αντιγονικα πολυπεπτιδια neisseira meningitidis (μηνιγγιτιδοκοκκου), αντιστοιχα πολυνουκλεοτιδια και προστατευτικα αντισωματα
DE60230456D1 (de) Faktor-viii-polypeptide auf hohem expressionsnivea und verwendungsverfahren
DE69907926D1 (de) 1,2,4-triazol-3-thion verbindungen